Epithelial-Mesenchymal Transition: Role in Cancer Progression and the Perspectives of Antitumor Treatment.

cancer cancer stem cells chemotherapy epithelial–mesenchymal transition immunotherapy metastasis resistance to anticancer therapy

Journal

Acta naturae
ISSN: 2075-8251
Titre abrégé: Acta Naturae
Pays: Russia (Federation)
ID NLM: 101525823

Informations de publication

Date de publication:
Historique:
entrez: 11 11 2020
pubmed: 12 11 2020
medline: 12 11 2020
Statut: ppublish

Résumé

About 90% of all malignant tumors are of epithelial nature. The epithelial tissue is characterized by a close interconnection between cells through cell-cell interactions, as well as a tight connection with the basement membrane, which is responsible for cell polarity. These interactions strictly determine the location of epithelial cells within the body and are seemingly in conflict with the metastatic potential that many cancers possess (the main criteria for highly malignant tumors). Tumor dissemination into vital organs is one of the primary causes of death in patients with cancer. Tumor dissemination is based on the so-called epithelial-mesenchymal transition (EMT), a process when epithelial cells are transformed into mesenchymal cells possessing high mobility and migration potential. More and more studies elucidating the role of the EMT in metastasis and other aspects of tumor progression are published each year, thus forming a promising field of cancer research. In this review, we examine the most recent data on the intracellular and extracellular molecular mechanisms that activate EMT and the role they play in various aspects of tumor progression, such as metastasis, apoptotic resistance, and immune evasion, aspects that have usually been attributed exclusively to cancer stem cells (CSCs). In conclusion, we provide a detailed review of the approved and promising drugs for cancer therapy that target the components of the EMT signaling pathways.

Identifiants

pubmed: 33173593
doi: 10.32607/actanaturae.11010
pmc: PMC7604894
doi:

Types de publication

Journal Article

Langues

eng

Pagination

4-23

Informations de copyright

Copyright ® 2020 National Research University Higher School of Economics.

Références

Cell. 2014 Aug 28;158(5):1110-1122
pubmed: 25171411
J Huazhong Univ Sci Technolog Med Sci. 2016 Dec;36(6):839-845
pubmed: 27924500
Eur J Cell Biol. 2016 Nov;95(11):503-512
pubmed: 27720259
J Cell Mol Med. 2006 Jan-Mar;10(1):76-99
pubmed: 16563223
Cancer Res. 2013 Jul 1;73(13):4147-57
pubmed: 23687336
Exp Cell Res. 2011 May 1;317(8):1119-33
pubmed: 21195710
Oncol Rep. 2017 Apr;37(4):2121-2128
pubmed: 28260043
J Biol Chem. 2013 Aug 9;288(32):22993-3008
pubmed: 23814079
Oncogenesis. 2019 Feb 19;8(3):13
pubmed: 30783098
Am J Transl Res. 2019 Jul 15;11(7):4277-4289
pubmed: 31396334
Nat Cell Biol. 2015 May;17(5):678-88
pubmed: 25893917
Cell Stem Cell. 2010 Jul 2;7(1):51-63
pubmed: 20621050
Oncoimmunology. 2018 Feb 15;7(4):e1345415
pubmed: 29632713
Thromb Haemost. 2003 Dec;90(6):993-1002
pubmed: 14652629
Mol Cancer Res. 2012 Dec;10(12):1597-606
pubmed: 23071104
Clin Cancer Res. 2010 Sep 15;16(18):4561-71
pubmed: 20823140
Biochim Biophys Acta Rev Cancer. 2017 Dec;1868(2):584-591
pubmed: 28669750
Cell. 2008 May 16;133(4):704-15
pubmed: 18485877
Sci Transl Med. 2014 Dec 3;6(265):265sr6
pubmed: 25473038
Science. 2001 Nov 23;294(5547):1708-12
pubmed: 11721053
Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):11494-11499
pubmed: 29073077
BMC Cancer. 2017 Feb 16;17(1):140
pubmed: 28209128
Am J Physiol Lung Cell Mol Physiol. 2009 Dec;297(6):L1120-30
pubmed: 19801454
Oral Oncol. 2018 May;80:23-32
pubmed: 29706185
Oncotarget. 2016 Dec 13;7(50):82609-82619
pubmed: 27655672
Mol Carcinog. 2017 Nov;56(11):2414-2423
pubmed: 28543713
Biol Pharm Bull. 2006 Oct;29(10):1991-4
pubmed: 17015938
Oncotarget. 2018 Jun 5;9(43):27242-27255
pubmed: 29930762
Br J Cancer. 2007 Apr 23;96(8):1246-52
pubmed: 17406365
J Clin Invest. 2007 Dec;117(12):3810-20
pubmed: 18037992
Clin Cancer Res. 2016 Jul 15;22(14):3630-42
pubmed: 26851185
Clin Breast Cancer. 2018 Oct;18(5):e1003-e1009
pubmed: 29526677
Oncogene. 2005 Mar 17;24(12):2032-41
pubmed: 15688013
Cell Prolif. 2018 Oct;51(5):e12473
pubmed: 30094882
Sci Rep. 2017 Dec 19;7(1):17753
pubmed: 29259250
Oncogene. 2017 May 4;36(18):2577-2588
pubmed: 28192397
Int J Cancer. 2016 Feb 15;138(4):949-63
pubmed: 26355710
Dev Dyn. 2019 Dec;248(12):1195-1210
pubmed: 31444829
Breast Cancer Res. 2003;5(2):101-6
pubmed: 12631389
Cancer Res. 2017 Nov 15;77(22):6415-6428
pubmed: 28947416
J Cell Biochem. 2019 Jan;120(1):848-860
pubmed: 30161276
Breast Cancer Res. 2014 Jun 02;16(3):R57
pubmed: 24890385
Anal Cell Pathol (Amst). 2018 Feb 27;2018:3506874
pubmed: 29682444
Int Immunol. 2005 Feb;17(2):133-44
pubmed: 15611321
Oncotarget. 2017 Jun 13;8(24):39280-39295
pubmed: 28424413
Cancer Med. 2017 Jan;6(1):220-234
pubmed: 27878981
Oncogene. 2007 Aug 23;26(39):5808-15
pubmed: 17353901
Am J Anat. 1977 Jan;148(1):85-119
pubmed: 842477
Dev Growth Differ. 2012 Aug;54(6):633-48
pubmed: 22775504
Am J Pathol. 1994 Oct;145(4):782-91
pubmed: 7943170
Cancer Chemother Pharmacol. 2019 May;83(5):975-991
pubmed: 30887178
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
BMC Cancer. 2012 Mar 19;12:91
pubmed: 22429801
Front Oncol. 2015 Jul 20;5:155
pubmed: 26258068
Cancer Res. 2012 May 15;72(10):2578-88
pubmed: 22589276
Oncotarget. 2018 May 11;9(36):24561-24571
pubmed: 29849961
Carcinogenesis. 2016 May;37(5):500-10
pubmed: 26933170
Acta Anat (Basel). 1995;154(1):8-20
pubmed: 8714286
Oncol Rep. 2018 Feb;39(2):483-490
pubmed: 29207201
Oncotarget. 2017 Mar 21;8(12):18949-18967
pubmed: 28145883
Genes Dev. 2004 May 15;18(10):1131-43
pubmed: 15155580
Cell Stem Cell. 2010 Jul 2;7(1):64-77
pubmed: 20621051
Oncol Rep. 2017 Oct;38(4):2277-2284
pubmed: 28849209
J Cell Physiol. 2005 Mar;202(3):858-66
pubmed: 15389643
Mol Carcinog. 2016 May;55(5):499-513
pubmed: 25728212
Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12293-7
pubmed: 12218188
Semin Cancer Biol. 2017 Aug;45:3-12
pubmed: 27491691
Cell Death Dis. 2018 May 29;9(6):649
pubmed: 29844404
J Biol Chem. 2007 Aug 3;282(31):22910-20
pubmed: 17556364
Mol Carcinog. 2018 Jan;57(1):125-136
pubmed: 28940757
Cancer Sci. 2018 Nov;109(11):3416-3427
pubmed: 30151927
Biochim Biophys Acta Mol Basis Dis. 2020 Apr 1;1866(4):165339
pubmed: 30481586
PLoS One. 2016 Jun 03;11(6):e0156904
pubmed: 27258152
Int J Oncol. 2014 Jun;44(6):1806-12
pubmed: 24691919
Cell. 2013 Dec 19;155(7):1639-51
pubmed: 24332913
Nat Cell Biol. 2014 Sep;16(9):864-75
pubmed: 25086746
J Int Oral Health. 2015 Sep;7(9):i-ii
pubmed: 26435637
Cell Rep. 2013 Dec 12;5(5):1228-42
pubmed: 24332369
Int Rev Cytol. 2005;243:287-335
pubmed: 15797462
Nat Rev Nephrol. 2011 Oct 18;7(12):684-96
pubmed: 22009250
Acta Pharm Sin B. 2019 May;9(3):484-495
pubmed: 31193822
Nat Commun. 2018 Aug 29;9(1):3503
pubmed: 30158554
J Cell Physiol. 2019 Mar;234(3):2037-2050
pubmed: 30343491
Gastroenterology. 2005 Nov;129(5):1375-83
pubmed: 16285938
Cancer Res. 2019 Apr 1;79(7):1658-1670
pubmed: 30737231
Cell Rep. 2015 Dec 22;13(11):2456-2469
pubmed: 26670048
Nat Cell Biol. 2017 Mar;19(3):224-237
pubmed: 28218910
N Engl J Med. 1994 Nov 10;331(19):1286-92
pubmed: 7935686
Nat Rev Mol Cell Biol. 2007 Jan;8(1):37-48
pubmed: 17183359
Cancer Res. 2010 Sep 1;70(17):6945-56
pubmed: 20699369
Oncol Lett. 2018 May;15(5):7144-7152
pubmed: 29731878
Sci Rep. 2017 Jul 7;7(1):4915
pubmed: 28687755
Cancer Genomics Proteomics. 2018 Mar-Apr;15(2):127-141
pubmed: 29496692
Nature. 2015 Apr 16;520(7547):353-357
pubmed: 25830880
Nature. 2015 Nov 26;527(7579):525-530
pubmed: 26560028
Oncogene. 2017 Jul 13;36(28):4001-4013
pubmed: 28288136
Nat Cell Biol. 2016 Nov;18(11):1221-1232
pubmed: 27749822
Mol Cancer Res. 2017 Aug;15(8):1029-1039
pubmed: 28373289
Nat Rev Mol Cell Biol. 2006 Feb;7(2):131-42
pubmed: 16493418
Thorac Cancer. 2018 Apr;9(4):423-430
pubmed: 29488330
Clin Cancer Res. 2019 Dec 1;25(23):6976-6985
pubmed: 31481511
Cancer Res. 2014 Nov 1;74(21):6330-40
pubmed: 25164016
Pathol Oncol Res. 2020 Jul;26(3):1639-1649
pubmed: 31512056
Cancer Res. 1999 Nov 1;59(21):5596-601
pubmed: 10554040
Nat Immunol. 2004 Jul;5(7):738-43
pubmed: 15170211
Cancer Med. 2018 Jul;7(7):3321-3330
pubmed: 29855157
J Dermatol Sci. 2009 Oct;56(1):19-26
pubmed: 19643582
Curr Top Dev Biol. 2015;112:353-82
pubmed: 25733146
Oncogene. 2017 Jul 27;36(30):4299-4310
pubmed: 28346424
Lung Cancer. 2016 Jul;97:87-94
pubmed: 27237033
Am J Transl Res. 2017 Sep 15;9(9):4217-4226
pubmed: 28979695
Cell. 2010 Apr 2;141(1):117-28
pubmed: 20371349
Stem Cells Int. 2018 Feb 28;2018:5416923
pubmed: 29681949
PLoS One. 2017 Mar 23;12(3):e0174487
pubmed: 28334049
Development. 2014 Apr;141(7):1503-13
pubmed: 24598159
Oncotarget. 2017 Jun 1;8(37):60727-60749
pubmed: 28977822
Nat Rev Genet. 2006 May;7(5):360-72
pubmed: 16619051
Sci Rep. 2018 Feb 13;8(1):2918
pubmed: 29440769
Matrix Biol. 2014 Sep;38:69-83
pubmed: 24951930
Mol Cancer. 2019 Jan 8;18(1):3
pubmed: 30621694
Annu Rev Cell Dev Biol. 2012;28:523-53
pubmed: 23057746
Oncogene. 2017 Nov 2;36(44):6067-6073
pubmed: 28714958
Oncogene. 2018 Nov;37(44):5843-5857
pubmed: 29980787
Proc Natl Acad Sci U S A. 2014 Apr 22;111(16):5908-13
pubmed: 24706882
Oncoimmunology. 2017 Jan 23;6(1):e1263412
pubmed: 28197390
Br J Cancer. 2010 Feb 16;102(4):639-44
pubmed: 20087353
Nat Cell Biol. 2017 May;19(5):518-529
pubmed: 28414315
Nat Commun. 2016 Feb 15;7:10711
pubmed: 26876487
Am J Pathol. 2010 May;176(5):2247-58
pubmed: 20304956
Oncotarget. 2017 Jan 17;8(3):4914-4921
pubmed: 27902486
Mol Cancer Ther. 2019 Feb;18(2):437-447
pubmed: 30401696
J Mol Biol. 2000 Jun 9;299(3):551-72
pubmed: 10835267
Cancer Med. 2017 Nov;6(11):2686-2696
pubmed: 28960866
Gastroenterology. 2006 Sep;131(3):830-40
pubmed: 16952552
Dev Cell. 2018 Jun 18;45(6):681-695.e4
pubmed: 29920274
Dev Cell. 2018 Jun 18;45(6):696-711.e8
pubmed: 29920275
PLoS One. 2017 Jul 6;12(7):e0180383
pubmed: 28683123
Mol Cell Biol. 2001 Dec;21(23):8184-8
pubmed: 11689706
Proc Natl Acad Sci U S A. 2016 May 3;113(18):4947-52
pubmed: 27091969
Cell Cycle. 2018;17(5):595-604
pubmed: 29157079
Cancer Cell. 2009 Mar 3;15(3):195-206
pubmed: 19249678
Gut. 2012 Mar;61(3):439-48
pubmed: 22147512
J Exp Clin Cancer Res. 2009 Feb 26;28:28
pubmed: 19243631
Curr Top Dev Biol. 2015;112:273-300
pubmed: 25733143
Oncogenesis. 2019 Oct 9;8(10):59
pubmed: 31597912
J Cell Biochem. 2017 Sep;118(9):2559-2570
pubmed: 28266048
J Cell Biol. 2014 Mar 3;204(5):839-56
pubmed: 24590176
Cell. 2005 Dec 2;123(5):903-15
pubmed: 16325583
Biochim Biophys Acta Mol Cell Res. 2017 Oct;1864(10):1887-1899
pubmed: 28779971
Semin Cancer Biol. 2015 Apr;31:16-27
pubmed: 24956577
Mol Cancer Res. 2017 Apr;15(4):478-488
pubmed: 28053127
Nature. 2017 Jul 5;547(7661):E1-E3
pubmed: 28682326
J Exp Med. 1995 Aug 1;182(2):459-65
pubmed: 7543139
Wound Repair Regen. 2008 Sep-Oct;16(5):585-601
pubmed: 19128254
Cancer Res. 2006 Dec 1;66(23):11271-8
pubmed: 17145872
Oncotarget. 2016 Oct 4;7(40):64527-64542
pubmed: 27590511
Gynecol Oncol. 2013 Jul;130(1):200-6
pubmed: 23542683
Anat Embryol (Berl). 1990;182(1):29-39
pubmed: 2122767
J Invest Dermatol. 2011 Feb;131(2):529-36
pubmed: 20962852
Oncogene. 2016 May;35(21):2687-97
pubmed: 26364599
Mol Cancer. 2017 Feb 28;16(1):52
pubmed: 28245823
Mol Cancer Res. 2017 Aug;15(8):1106-1116
pubmed: 28461325
Cell Cycle. 2009 Sep 15;8(18):2901-6
pubmed: 19713745
Mol Oncol. 2017 Jul;11(7):805-823
pubmed: 28599100
Sci Rep. 2019 Oct 2;9(1):14140
pubmed: 31578396
Cell Mol Neurobiol. 2019 Aug;39(6):769-782
pubmed: 31011939
Adv Wound Care (New Rochelle). 2013 Jul;2(6):261-272
pubmed: 24527348
PLoS One. 2008 Aug 06;3(8):e2888
pubmed: 18682804
Oncoimmunology. 2018 Feb 1;7(5):e1423170
pubmed: 29721376
Cancer Res. 2005 Jul 15;65(14):5996-6000; discussion 6000-1
pubmed: 16024596
Oncogene. 2017 Apr 6;36(14):1925-1938
pubmed: 27694892
Cell Death Dis. 2019 Jun 13;10(6):467
pubmed: 31197132
Histochem Cell Biol. 2008 Sep;130(3):509-25
pubmed: 18496706
Cancer Cell. 2012 Dec 11;22(6):725-36
pubmed: 23201165
Curr Top Dev Biol. 2015;111:27-67
pubmed: 25662257
Acta Anat (Basel). 1995;154(1):79-97
pubmed: 8714291
J Immunother Cancer. 2019 Jul 11;7(1):177
pubmed: 31296256
Nature. 2015 Nov 26;527(7579):472-6
pubmed: 26560033
Oncoimmunology. 2017 Apr 20;6(12):e1315488
pubmed: 29209560
Nat Med. 2002 Aug;8(8):793-800
pubmed: 12091876
PLoS One. 2018 Apr 24;13(4):e0192436
pubmed: 29689047
Acta Anat (Basel). 1995;154(1):63-78
pubmed: 8714290
Cancer Cell Int. 2017 Jan 5;17:6
pubmed: 28070168
J Cell Biol. 2000 Mar 6;148(5):1075-90
pubmed: 10704455
Differentiation. 2013 Oct;86(3):126-32
pubmed: 23660532
Nat Med. 2003 Jul;9(7):964-8
pubmed: 12808448
Dev Cell. 2006 Nov;11(5):601-12
pubmed: 17084354
Biochem Biophys Res Commun. 2017 Apr 1;485(2):556-562
pubmed: 27923652
Sci Rep. 2017 Jun 21;7(1):4002
pubmed: 28638102
Breast Cancer. 2018 Jul;25(4):447-455
pubmed: 29536377
Science. 2013 Feb 1;339(6119):580-4
pubmed: 23372014
J Immunol. 2001 Jun 15;166(12):7556-62
pubmed: 11390511
Science. 2016 Apr 8;352(6282):167-9
pubmed: 27124449
Dev Biol. 1989 Feb;131(2):455-74
pubmed: 2463946
Cancers (Basel). 2018 Dec 13;10(12):
pubmed: 30551687
Transl Lung Cancer Res. 2015 Apr;4(2):110-8
pubmed: 25870793
Cancer Cell. 2008 Jul 8;14(1):79-89
pubmed: 18598946
Sci Rep. 2018 Aug 6;8(1):11739
pubmed: 30082842
J Biol Chem. 2012 Feb 10;287(7):4441-50
pubmed: 22174415
Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):E2337-E2346
pubmed: 28270621
Cell. 2005 Dec 2;123(5):889-901
pubmed: 16325582
Cancer Cell Int. 2017 May 12;17:54
pubmed: 28507454
Yonsei Med J. 2018 Jan;59(1):35-42
pubmed: 29214774
Cancers (Basel). 2019 May 02;11(5):
pubmed: 31052565
Tissue Barriers. 2017 Jul 3;5(3):e1356900
pubmed: 28783415
Int Immunopharmacol. 2018 Sep;62:29-39
pubmed: 29990692
Cell. 2017 Dec 14;171(7):1611-1624.e24
pubmed: 29198524
Cell. 2007 Nov 30;131(5):861-72
pubmed: 18035408
Biomed Res Int. 2018 Jan 11;2018:4174232
pubmed: 29568752
Mol Cancer. 2017 Jul 17;16(1):124
pubmed: 28716029
J Clin Oncol. 2012 Feb 10;30(5):525-32
pubmed: 22253462
Tumour Biol. 2016 Jun;37(6):7245-54
pubmed: 26666820
Cancer Res. 2010 Jul 15;70(14):5649-69
pubmed: 20610625
Cancer Res. 2017 Jul 1;77(13):3417-3430
pubmed: 28473532
Oncogene. 2013 May 2;32(18):2249-60, 2260.e1-21
pubmed: 22777357
PLoS One. 2019 Jul 16;14(7):e0219317
pubmed: 31310624
Oncogenesis. 2018 May 8;7(5):38
pubmed: 29735981
PLoS One. 2017 Aug 17;12(8):e0183578
pubmed: 28817737
Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):E854-63
pubmed: 26831077
Oncol Rep. 2017 Oct;38(4):2401-2407
pubmed: 28765915
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10356-61
pubmed: 11526241
Mol Cancer Res. 2017 Dec;15(12):1764-1776
pubmed: 28851812
Circ Res. 2002 Jun 14;90(11):1189-96
pubmed: 12065322
Nature. 2015 Sep 10;525(7568):256-60
pubmed: 26331542
Stem Cells. 2009 Sep;27(9):2059-68
pubmed: 19544473
Oncogene. 2017 Feb 16;36(7):885-898
pubmed: 27694898
Reproduction. 2012 Mar;143(3):377-87
pubmed: 22157247
Nature. 2017 Jul 5;547(7661):E7-E8
pubmed: 28682339
J Cancer. 2017 Apr 9;8(7):1123-1128
pubmed: 28607585
EMBO Mol Med. 2014 Sep 11;6(10):1279-93
pubmed: 25214461
Dev Dyn. 2007 Sep;236(9):2493-501
pubmed: 17676634
J Pathol. 2003 Jul;200(4):500-3
pubmed: 12845617
J Hematol Oncol. 2019 Mar 4;12(1):21
pubmed: 30832692
Oncotarget. 2016 Mar 29;7(13):15901-14
pubmed: 26893364
Clin Cancer Res. 2016 Jul 15;22(14):3571-81
pubmed: 26864211
Oncogene. 2019 Jan;38(5):656-670
pubmed: 30171258
Nat Rev Clin Oncol. 2015 Oct;12(10):584-96
pubmed: 26122183
Eur Rev Med Pharmacol Sci. 2013 Jul;17(13):1722-9
pubmed: 23852894
Mol Cancer Res. 2011 Aug;9(8):997-1007
pubmed: 21665936
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):40-5
pubmed: 20018687
Oncotarget. 2016 May 31;7(22):33316-30
pubmed: 27119231
Cytokine Growth Factor Rev. 2003 Oct;14(5):391-407
pubmed: 12948523
Br J Cancer. 2011 Oct 25;105(9):1338-41
pubmed: 21970878
Mol Cancer Res. 2017 Jun;15(6):723-734
pubmed: 28213554
Development. 2012 Oct;139(19):3471-86
pubmed: 22949611
Oncogenesis. 2017 Jan 9;6(1):e284
pubmed: 28067907
Med Oncol. 2016 Feb;33(2):15
pubmed: 26749588
Mol Oncol. 2017 Jul;11(7):824-846
pubmed: 28614624
Clin Cancer Res. 2015 Mar 1;21(5):962-968
pubmed: 25107915
Cell. 2014 Mar 13;156(6):1298-1311
pubmed: 24630729
Biochem Biophys Res Commun. 2018 Feb 5;496(2):770-777
pubmed: 29337056
Cell Rep. 2016 Jul 19;16(3):657-71
pubmed: 27396341
J Cell Biol. 1982 Oct;95(1):333-9
pubmed: 7142291
Science. 1996 Mar 22;271(5256):1734-6
pubmed: 8596936
Clin Cancer Res. 2009 Apr 15;15(8):2657-65
pubmed: 19336515
Mol Biol Cell. 2016 Nov 1;27(21):3233-3244
pubmed: 27582386

Auteurs

A V Gaponova (AV)

Moscow Institute of Physics and Technology, Dolgoprudny, Moscow Region, 141701 Russia.

S Rodin (S)

Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, 17177 Sweden.

A A Mazina (AA)

Moscow Institute of Physics and Technology, Dolgoprudny, Moscow Region, 141701 Russia.

P V Volchkov (PV)

Moscow Institute of Physics and Technology, Dolgoprudny, Moscow Region, 141701 Russia.

Classifications MeSH